Stock Market Today, Feb. 23: ImmunityBio Surges After Anktiva Revenue Jumps 700%

Market Intelligence Analysis

AI-Powered
Why This Matters

ImmunityBio's stock surged due to Anktiva's 700% revenue jump, but the company's own deep losses and ambitious expansion plans are being weighed by investors.

Market Impact

Market impact analysis based on bullish sentiment with 70% confidence.

Sentiment
Bullish
AI Confidence
70%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

On Feb. 23, 2026, investors weighed ANKTIVA’s explosive revenue ramp against ImmunityBio’s deep losses and ambitious global expansion.

Continue Reading
Full article on Yahoo Finance
Read Full Article
Original article published by Yahoo Finance on February 24, 2026.
Analysis and insights provided by AnalystMarkets AI.